Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
VIPR1 encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Zusätzlich bieten wir Ihnen Vasoactive Intestinal Peptide Receptor 1 Kits (15) und Vasoactive Intestinal Peptide Receptor 1 Proteine (6) und viele weitere Produktgruppen zu diesem Protein an.
Showing 10 out of 112 products:
Human Polyclonal VIPR1 Primary Antibody für WB - ABIN1881994
Mlakar, Strazisar, Sok, Glavac: Oligonucleotide DNA microarray profiling of lung adenocarcinoma revealed significant downregulation and deletions of vasoactive intestinal peptide receptor 1. in Cancer investigation 2010
Show all 2 Pubmed References
Human Polyclonal VIPR1 Primary Antibody für IHC (p) - ABIN4365549
Berger, Vistisen, Barrett, Hazlett: Effects of VIP on corneal reconstitution and homeostasis following Pseudomonas aeruginosa induced keratitis. in Investigative ophthalmology & visual science 2012
Human Polyclonal VIPR1 Primary Antibody für ICC, IF - ABIN4365551
Bertolini, Pretzlaff, Sulk, Bähr, Gherardini, Uchida, Reibelt, Kinori, Rossi, Bíró, Paus: Vasoactive intestinal peptide, whose receptor-mediated signalling may be defective in alopecia areata, provides protection from hair follicle immune privilege collapse. in The British journal of dermatology 2016
In vitro-polarized macrophages by GM-CSF (zeige CSF2 Antikörper) (GM-MO), with a proinflammatory profile, expressed higher levels of VIP (zeige Vip Antikörper) receptors, vasoactive intestinal polypeptide (zeige Vip Antikörper) receptors 1 and 2 (VPAC1 and VPAC2 (zeige VIPR2 Antikörper), respectively), than macrophages polarized by M-CSF (zeige CSF1 Antikörper) (M-MO) with anti-inflammatory activities. RA synovial macrophages, according to their GM-CSF (zeige CSF2 Antikörper)-like polarization state, expressed both VPAC1 and VPAC2 (zeige VIPR2 Antikörper).
VPAC1 rs9677 CC genotype could be correlated with a reduced response to statin therapy and seems to be involved in diabetes cardiomyopathy in female patients with type 2 diabetes.
The results reveal that more severe inflammation, based on high levels of IL-6 (zeige IL6 Antikörper), is associated with lower expression of VPAC1 and, conversely, with increased expression of VPAC2 (zeige VIPR2 Antikörper).
variations at the 3'UTR (zeige UTS2R Antikörper) of the VPAC-1 gene act synergistically to affect the expression of the luciferase as well as of the GFP reporter genes expressed in HEK293T cells.
These data suggest that VPAC1 overexpression is associated with poorer differentiation of colon cancer, which is likely caused by subsequent EGFR (zeige EGFR Antikörper) activation in cancer cells.
VIP (zeige Vip Antikörper) regulates CFTR (zeige CFTR Antikörper) membrane expression and function in Calu (zeige CALU Antikörper)-3 cells by increasing its interaction with NHERF1 (zeige SLC9A3R1 Antikörper) and P-ERM (zeige ETV5 Antikörper) in a VPAC1- and PKCepsilon (zeige PRKCE Antikörper)-dependent manner.
VPAC1 receptor has a role in endotoxemia in peripheral blood mononuclear cells
The overexpression of VPAC1 and VPAC2 (zeige VIPR2 Antikörper) receptors and COX-2 (zeige COX2 Antikörper) in cancer tissue gives them a potential role as targets for diagnosis of prostate cancer.
hree residues play an important role in VPAC1 interaction with the first histidine residue of VIP (zeige Vip Antikörper). These data demonstrate that VIP (zeige Vip Antikörper) and PG97-269 bind to distinct domains of VPAC1
The genetic association reported here indicates that VIP (zeige Vip Antikörper)/VPAC1 signaling can be a relevant pathway in the pathogenesis of type 2 diabetes in females
This study demonstrated that VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage.
VPAC1R mRNA expression was significantly decreased 3 days after ischemia induced by bilateral common carotid artery occlusion
Cyclophosphamide-induced cystitis decreased VPAC1 receptor transcript expression in the urothelium of WT (4 h, 48 h, & chronic) & NGF (zeige NGFB Antikörper)-OE mice.
Data support the notion that both VPAC1 and VPAC2 (zeige VIPR2 Antikörper) receptors are dynamically regulated by Ikaros (zeige IKZF1 Antikörper), a master transcriptional regulator for thymocyte differentiation, during early thymic development.
results support that decline in VIP (zeige Vip Antikörper)/VPAC local levels may influence survival/apoptosis intracellular set point in NOD acinar cells and their clearance, contributing to gland homeostasis loss in a model of Sjogren's syndrome
Homozygous deletion of VPAC1 resulted in fetal, neonatal, and postweaning death owing to failure to thrive, intestinal obstruction, and hypoglycemia.
VIP (zeige Vip Antikörper) enhancement of the severity of dextran sodium sulfate-induced colitis is mediated solely by VPAC1 receptors in mice.
Data describe PACAP (zeige ADCYAP1 Antikörper), vasoactive intestinal polypeptide (zeige Vip Antikörper), and PAC1 (zeige ADCYAP1R1 Antikörper), VPAC1, VPAC2 (zeige VIPR2 Antikörper) transcripts or protein expression in urothelium and detrusor smooth muscle and lumbosacral dorsal root ganglia in NGF (zeige NGFB Antikörper)-overexpressing and wildtype mice.
VPAC(1)-R activation aggravates atherosclerotic lesion formation in apolipoprotein E (zeige APOE Antikörper)-deficient mice through enhanced inflammatory activity in the vessel wall.
VIP (zeige Vip Antikörper) and its receptors (VPAC1, VPAC2 (zeige VIPR2 Antikörper)) were identified in type II taste cells of the taste bud, and VIP (zeige Vip Antikörper) knockout mice exhibit enhanced taste preference to sweet tastants.
Implanting vascular bundles into the tissue engineered bone can significantly improve the expression levels of NK1R (zeige TACR1 Antikörper) and VIPR1.
The study confirmed the presence of VPAC1 receptor in the tissues of the porcine female reproductive tract what clearly shows the possibility of influence of vasoactive intestinal polypeptide (zeige Vip Antikörper) on the porcine ovary, oviduct and uterus.
This gene encodes a receptor for vasoactive intestinal peptide, a small neuropeptide. Vasoactive intestinal peptide is involved in smooth muscle relaxation, exocrine and endocrine secretion, and water and ion flux in lung and intestinal epithelia. Its actions are effected through integral membrane receptors associated with a guanine nucleotide binding protein which activates adenylate cyclase. Several transcript variants encoding different isoforms have been found for this gene.
PACAP type II receptor
, VIP and PACAP receptor 1
, VIP receptor, type I
, pituitary adenylate cyclase activating polypeptide receptor, type II
, vasoactive intestinal polypeptide receptor 1
, VIP receptor subtype 1
, pituitary adenylate cyclase-activating polypeptide type II receptor
, Vasopressive intestinal peptide receptor
, vasoactive intestinal peptide receptor 1
, vasoactive intestinal polypeptide receptor 1-like
, vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide receptor 1
, vpac1 receptor
, vasoactive intestinal polypeptide receptor type 1
, VIP receptor
, Vasoactive intestinal polypeptide receptor